Une nouvelle approche de traitement des

!"##$%&&'''()*+,-./
+-01$".,.2(0*3&24#.&4,5.6($"$70$#40,8-09:-0,#.,#;#+2<8=4.';458>>?;@#.9458A?BC
Page 1 sur 4C
C
Une$nouvelle$approche$de$traitement$des$acouphènes$:$
D#15.CE.1*0FG2#.-C
H(CI*+-".#C
CC
Introduction$$
J,C,01=.KC.22+4C-K4,4L1.C$01*CK.C#*+4#.9.,#C5.2C+-01$"M,.2C1#4K42+,#C1,C,01=.+1C
9N54-+9.,#C4,2#4KKNC54*.-#.9.,#C5+,2CKO0*.4KK.C4,#.*,.C.2#C.,C-01*2(CPQN#15.C.2#C9.,N.C
$+*CK.C2.*=4-.C5OR#0CS"4,0CP+*G,30K034.C5.CKQ"T$4#+KCU=4-.,,.CVWXYYYCH0Z43,G[\C5+,2CK.C
].,#*.C5O@,=.2#43+#40,C]K4,4L1.C5.C-.C9^9.C"T$4#+K(C].##.CN#15.\CL14C-09$*.,5C_CK+C)042C
KON=+K1+#40,C51C9N54-+9.,#C.#C5.C20,C542$024#4)C5O4,2#4KK+#40,C*.-".*-".C5.2C+51K#.2C
201))*+,#C5O+-01$"M,.2C4,=+K45+,#2\C5O1,C2.1KC-T#N\C+=.-C1,.C21*54#NC2N=M*.C01C$*0)0,5.\C
51C9^9.C-T#N(CC
C
À$propos$de$traitement$des$acouphènes,$en$général$
$
U1C-01*2C5.C-.2C5.*,4M*.2C+,,N.2\CK+C-09$*N".,240,C5.2C-+12.2C5.CKQ+-01$"M,.C2Q.2#C
3*+,5.9.,#C+9NK40*N.(C`01*#+,#\C1,.C3*+,5.C=+*4N#NC5.C)+-#.1*2C$.1=.,#C^#*.C_CKQ0*434,.C
5.C-.C2G9$#T9.(CR,C$.1#C-4#.*C$+*C.6.9$K.%CK.2C#*+19+#429.2C20,0*.2\CK+C$.*#.C+154#4=.C
2015+4,.\CK.2C9N54-+9.,#2C54#2CaC0#0#064L1.2Cb\CK.2C#*+19+#429.2C54*.-#2C.#CKO4,).-#40,C5.C
KO0*.4KK.C4,#.*,.cCC
C
F-"N9+#4L1.9.,#\CK+C$*42.C.,C-"+*3.C5.2C+-01$"M,.2C214#CXC+6.2C%CC
C
P.C$*.94.*C.2#C5O+9NK40*.*CK+C#0KN*+,-.C5.C$K124.1*2C)+d0,2\C+=.-C01C2+,2C9N54-+9.,#2\C
.,C=012C$*0$02+,#C1,.C#"N*+$4.C-09$0*#.9.,#+K.C.#C-03,4#4=.\C.,C5N=.K0$$+,#C1,.C
"+Z4#1+#40,(CC
C
P.C5.164M9.C=42.C_C+9NK40*.*CKO+154#40,(CP+C$K1$+*#C5.2C+-01$"M,.2C21*=4.,,.,#C21*C1,.C
0*.4KK.C$K12C01C904,2C9+K.,#.,5+,#.(CPO+154#40,C.2#C,0,C2.1K.9.,#C904,2C.))4-+-.\C9+42C
.2#C5.C$K12C5N2+3*N+ZK.C51C)+4#C5.CKO+-01$"M,.\C.#C$K12CK+C$.*20,,.C#.,5CKO0*.4KK.C$01*C
-09$*.,5*.\C$K12C.KK.C$.*d04#C20,C+-01$"M,.(CU9NK40*.*CKO+154#40,C.2#CK.C5.164M9.C+6.\C
$+*C0$N*+#40,C-"4*1*34-+K.\C$+*C$*0#"M2.C+154#4=.cCP+C24#1+#40,C.2#C$K12C54))4-4K.CL1+,5C
KO0*.4KK.C.2#C#*M2C01C-09$KM#.9.,#C201*5.cC2+,2C$01=04*C$*0)4#.*C5O1,.C$*0#"M2.(C`01*C
)01*,4*C1,.C2.,2+#40,C20,0*.C0,C$.1#C$*0$02.*C1,.C2#491K+#40,CNK.-#*4L1.CC
C
P.C#*0424M9.C+6.C.2#C5.CK1##.*C-0,#*.CK.C9N-+,429.C9^9.C5.CKO+-01$"M,.(Ce,C.)).#C$01*C
.6$K4L1.*CK.C2G9$#T9.C+-01$"M,.\C4KCGC+C.22.,#4.KK.9.,#C1,C2.1KC9N-+,429.\CL14C5094,.\C
+1C904,2C_CK+C$"+2.C5.C5NZ1#C%C]O.2#CKO"G$.*+-#4=4#NC,.*=.12.C21*CK.2C=04.2C5.CKO+154#40,(C
]O.2#C-.##.C"G$.*+-#4=4#NCL14C.2#C$.*d1.C-099.C1,C20,\C-O.2#CKf+-01$"M,.(C`+*C.6.9$K.\C
5+,2CK.C#*+19+#429.C20,0*.\C#01#C2.C$+22.C-099.C2O4KC.642#+4#C1,.CaCN$4K.$24.CbC5.CK+C=04.C
,.*=.12.C+154#4=.(CC
C
Un$médicament$dans$l’oreille$interne:$le$NST$001$$
C
`01*CK1##.*C-0,#*.C-.##.C"G$.*+-#4=4#N\CK.2C#*+4#.9.,#2C+594,42#*N2C$+*C=04.C0*+K.\CL1+,5C
4K2C20,#C.))4-+-.2\C$.1=.,#C^#*.C*.2$0,2+ZK.2C5O.)).#2C2.-0,5+4*.2(CU4,24CKO.)).#C2.-0,5+4*.C
5O1,C,.1*0K.$#4L1.C.2#CK+C209,0K.,-.(CP14C9^9.C$.1#C^#*.C*.-".*-"NCL1+,5CKO+-01$"M,.C

!"##$%&&'''()*+,-./
+-01$".,.2(0*3&24#.&4,5.6($"$70$#40,8-09:-0,#.,#;#+2<8=4.';458>>?;@#.9458A?BC
Page 2 sur 4C
C
.2#C*.2$0,2+ZK.C5.C#*01ZK.2C3^,+,#2C5.CKO.,50*9422.9.,#(Cg+42C-.C,O.2#C$K12C5.CK+CK1##.C
-0,#*.CK.C9N-+,429.C5.CKO+-01$"M,.C9+42C51C#*+4#.9.,#C5.CK+C#0KN*+,-.(CC
]09$#.C#.,1C5.CK+C-09$K.64#NC5.2C-+12.2\C51C-+*+-#M*.C#*M2C21Zh.-#4)C51C2G9$#T9.CK14/
9^9.\C5.CKO49$K4-+#40,C)0*#.C5.2C-0,54#40,2C5.C=4.C$.*20,,.KK.2C5.C-.K14CL14C201))*.C
5O+-01$"M,.2cCK+CL1+,#4)4-+#40,C5.2C$*03*M2C+$$0*#N2C$+*CK.C#*+4#.9.,#C.2#C5NK4-+#.C%CK.2C
N#15.2C-K4,4L1.2C20,#C>Ci0-19.,#C$1ZK4-4#+4*.\C=.*240,CK0,31.\C=.*240,C)*+,d+42.C5+#NC51C
>Ch14,C>YYWCC
54))4-4K.2(C@KC)+1#C*.3*01$.*CK.2C$+#4.,#2C.,C3*01$.2C-K4,4L1.2C"0903M,.2C%C+-01$"M,.2C
*N-.,#2\C+-01$"M,.2C-"*0,4L1.2\C+-01$"M,.2C$K1#T#C$N*4$"N*4L1.2CV5.CKO0*.4KK.C4,#.*,.C
.22.,#4.KK.9.,#[\C01C+-01$"M,.C-.,#*+KcCP+C9N5.-4,.C+-#1.KK.CN#+,#C)0,5N.C21*C5.2C
$*.1=.2\CK+C942.C+1C$04,#C5.C$*0514#2C,01=.+16C$01*CK.2C+-01$"M,.2C.2#C*+*.(CC
C
L’étude$en$cours$teste$un$nouveau$traitement$de$l'acouphène.$$
C
P+C*.-".*-".C5.2CAjC5.*,4M*.2C+,,N.2C+C-0,514#C_CK+C5N-01=.*#.C5.C,01=.+16C
9N54-+9.,#2C+=.-C1,.C)0*#.C+-#4=4#NC21*CK+C#*+,2942240,C5.CKO4,)K16C,.*=.16(C`01*C*.K4.*C_C
-.CL14C+CN#NC54#C$K12C"+1#\C1,.C+$$K4-+#40,C#01#.C#*01=N.C.2#CKO"G$.*+-#4=4#NC,.*=.12.C5.C
KO+-01$"M,.(CJ,C9N54-+9.,#C$*09.##.1*C+CN#NC5N-01=.*#C$+*C5.2C-".*-".1*2C5.C
g0,#$.KK4.*(Ce,CK+Z0*+#04*.\C-.C9N54-+9.,#CVEFk/YYA[C+C90,#*NC1,.C.))4-+-4#NC21*C
KO+-01$"M,.C4,514#C-".lCKO+,49+KC$+*C5.2C5*031.2CaC+5C"0-CbcC5.C$K12C.#C".1*.12.9.,#\C
-.C9N54-+9.,#C2Q.2#C+=N*NC2+,2C5+,3.*CK0*2C5.CKQ1#4K42+#40,C-".lCKQ"099.(CE.1*0FG2#.-C+C
*N-.99.,#C0Z#.,1CKQ+$$*0Z+#40,C5.2C0*3+,429.2C-09$N#.,#2C$01*C#.2#.*C-.C
9N54-+9.,#C$01*CKO4,54-+#40,C+-01$"M,.2C.,CI*+,-.C%CC
C
EFk/YYAC+CN#NC*4301*.12.9.,#C#.2#NCK0*2C5ON#15.2C5.C2N-1*4#NC.#C+C50,-CN#NC+$$*01=NC
$01*C1,.C$*.94M*.CN#15.C-".lCKQ"099.CV.22+4C-K4,4L1.C5.C$"+2.CAZ[C$+*CKQUIFFU`FC.#C1,C
-094#NC5QN#"4L1.CV]``[C50,#CK+C*.2$0,2+Z4K4#NC.2#C5O+$$*01=.*CK.C-+*+-#M*.CN#"4L1.C5.C
KO.22+4(C].#C.22+4C5.C$"+2.CAZC=+C5NZ1#.*C.#C2.*+C-0,514#C_CKQmT$4#+KCU=4-.,,.\C2012CK+C
54*.-#40,C5Q1,.CNL14$.C5.C9N5.-4,2\C)+94K4+*42N2C+=.-CK+C-0,514#.C5Q.22+42C-K4,4L1.2C.#C51C
#*+4#.9.,#C5.2C+-01$"M,.2(CC
C
L'étude$clinique$est$conçue$pour$démontrer$la$sécurité$du$traitement$et$pour$
savoir$si$le$médicament$permet$de$supprimer$la$perception$de$l'acouphène.$$
C
Quelle$est$l’action$de$ce$nouveau$médicament?$$
C
].##.C,01=.KK.C#"N*+$.1#4L1.C9.##*+C_CKQN$*.1=.CK+C#"N0*4.C2.K0,CK+L1.KK.CK+C*N51-#40,C5.C
KQ"G$.*+-#4=4#NC51C,.*)C+154#4)C51.C_C1,.CKN240,C5.CKO0*.4KK.C4,#.*,.C.2#C1#4K.C+16C$+#4.,#2C
L14C201))*.,#C5O+-01$"M,.2C3*+=.2\C9+KC#0KN*N2(CPQN#15.C2.*+C+6N.C21*CK.2C+-01$"M,.2C
5O+$$+*4#40,C*N-.,#.\C1,4K+#N*+16\C+--09$+3,N2C5.C21*54#NC49$0*#+,#.CL14C,.C$.*9.#C$+2C
KO.9$K04C5O1,.C$*0#"M2.C+154#4=.C$01*CK+C-09$.,2.*(CC
PQN#15.C=+C-0,242#.*C.,C1,.C4,2#4KK+#40,C51C9N54-+9.,#CVEFk/YYA[C54*.-#.9.,#C5+,2C
KO0*.4KK.C4,#.*,.CV-0-"KN.[C_C$K124.1*2C*.$*42.2C$.,5+,#C1,C9+64919C5.C>Ch01*2(CPON#15.C
-".*-".C+1224C_C=+K45.*CK.C542$024#4)C5O4,h.-#40,C%CK.C9N54-+9.,#C2.*+C4,#*0514#C_CZ0,,.C
-0,-.,#*+#40,C$+*C1,C#1Z.C94-*02-0$4L1.C54*.-#.9.,#C5+,2CK+C-0-"KN.(C].C#1Z.C2.*+C*.K4NC
_C1,.C$09$.C-0,#.,+,#C1,.C2.*4,31.C+=.-CK.CEFk/YYA(C].C#1Z.C2.*+C49$K+,#NC
-"4*1*34-+K.9.,#C5+,2CK+C-0-"KN.C.#C$K12C$+*#4-1K4M*.9.,#C$+*CK+C).,^#*.C*0,5.\C.,C
#*+=.*2+,#CK+C9.9Z*+,.C5.C-.##.C).,^#*.CV=04*CK.C2-"N9+[(CC

!"##$%&&'''()*+,-./
+-01$".,.2(0*3&24#.&4,5.6($"$70$#40,8-09:-0,#.,#;#+2<8=4.';458>>?;@#.9458A?BC
Page 3 sur 4C
C
e,C$*+#4L1.\C2012C+,.2#"N24.C3N,N*+K.C01CK0-+K.\CK+C9.9Z*+,.C#G9$+,4L1.C2.*+C*N-K4,N.C
$01*C.6$02.*C-.##.Cl0,.C+,+#094L1.C%CK+C).,^#*.C5.CKQ0*.4KK.C4,#.*,.(CnCK+C)4,C5.CK+C$N*405.C
5O"02$4#+K42+#40,C5.C>Ch01*2\CK.C#1Z.C2.*+C*.#4*N(Ck01#C+1CK0,3C5.C-.##.C$"+2.C+=.-C
49$K+,#+#40,C51C#1Z.\CK.2C.)).#2C51C9N54-+9.,#C2.*0,#CN=+K1N2C+=.-C502+3.C5.C54=.*2.2C
-0,2#+,#.2CZ40K034L1.2C.#C21*=.4KK+,-.C9N54-+K.(CU$*M2C*.#*+4#C51C#1Z.\C+$*M2CK+C$N*405.C
5O"02$4#+K42+#40,C$*.,5*+C+K0*2C$K+-.C1,C214=4C9N54-+KC+)4,C5QN=+K1.*CK.2C.)).#2C_CK0,3C
#.*9.C51C#*+4#.9.,#\C#+,#C21*CK.2C.)).#2C$024#4)2C51C9N54-+9.,#CL1.C21*C2.2CN=.,#1.K2C
.)).#2C2.-0,5+4*.2(CC
I+4#C49$0*#+,#C.#CL14Ch12#4)4.C-.C905.C5O+594,42#*+#40,\CKQ+594,42#*+#40,C54*.-#.C51C
9N54-+9.,#C5+,2CK+C-0-"KN.C*N514#C-0,245N*+ZK.9.,#CK+CL1+,#4#NC5.C9N54-+9.,#C
542#*4Z1NC5+,2CKO0*3+,429.C%CC
K.2C.)).#2C2.-0,5+4*.2C$0224ZK.2C20,#C+4,24C94,4942N2(Ci.C$K12\CK.C24#.C5O4,2#4KK+#40,C5+,2C
KO0*.4KK.C4,#.*,.C.2#C-K02C.#CK.C$*0514#C,.C54))12.C$+2(C].-4CN=4#.C.,-0*.CK.2C.)).#2C3N,N*+16(CC
`.,5+,#CK.2CoC9042C5.CKON#15.\CK.C$+#4.,#C2.*+C4,=4#NC_C-0,243,.*C2.2C0Z2.*=+#40,2\C
KO49$0*#+,-.C5.C2.2C+-01$"M,.2\CK.2C-"+,3.9.,#2CL14C2.C$*05142.,#(CUC$+*#4*C5.2C
0Z2.*=+#40,2C$+*CK.2C9N5.-4,2\C$+*C=012C9^9.\C4KC2.*+C$0224ZK.C5.C5N#.*94,.*CK+C2N-1*4#NC
.#CKO.))4-+-4#NC5.C-.C9N54-+9.,#(Ck012CK.2C$+#4.,#2C*.-.=*0,#CK.C9N54-+9.,#C%C4KC,.C2O+34#C
$+2C5O1,.CN#15.C54#.C.,CaC+=.13K.CbC-O.2#C_C54*.C-0,#*.C1,C$K+-.Z0(CC
C
Qui$parraine$l'étude?$$
C
].##.CN#15.C.2#C0*3+,42N.C$+*CE.1*0FG2#.-C]0*$0*+#40,A\C1,.C.,#*.$*42.C
$"+*9+-.1#4L1.C+16CD#+#2/J,42CL14C5N=.K0$$.C5.2C20K1#40,2C#"N*+$.1#4L1.2C$01*CK.2C
+-01$"M,.2\C-O.2#C_C54*.C_CK+C)042C9N54-+9.,#2C.#C542$024#4)2C5O+594,42#*+#40,C5.C-.2C
9N54-+9.,#2(CPQ0Zh.-#4)C5.CE.1*0FG2#.-C.2#C5.C5N=.K0$$.*C1,C2G2#M9.C.,#4M*.9.,#C
49$K+,#+ZK.C$01*CK.C#*+4#.9.,#C5.2C+-01$"M,.2C$.*9.##+,#C1,C#*+4#.9.,#C$*0K0,3NC+=.-C
1,CZN,N)4-.C_CK0,3C#.*9.(CC
C
Comment$puisHje$bénéficier$de$ce$médicament?$$
C
].C9N54-+9.,#C.2#C.,-0*.C.,C$"+2.C5.C*.-".*-".(CJ,C$*0#0-0K.C5ON#15.C-K4,4L1.C-".lCK.2C
+51K#.2C+CN#NC+$$*01=NC$+*CK.2C#1#.KK.2C5.C2+,#NC.,CI*+,-.CV]094#NC5.C$*0#.-#40,C5.2C
$.*20,,.2C$"G24L1.2Cp]``/\CU3.,-.C)*+,d+42.C5.2C$*0514#2C5.CF+,#NCpCUIFFU`F[(C`01*C
-"+L1.C-+,545+#\C0,C.6+94,.*+CK.2CZN,N)4-.2C$0224ZK.2C5.C-.C#*+4#.9.,#(C`K12C
5Q4,)0*9+#40,2C21*C-.##.CN#15.C=012C2.*0,#C50,,N.2C$+*C=0#*.C9N5.-4,C.#C$+*CK.2C
*.2$0,2+ZK.2C9N54-+16C5.C-.##.CN#15.(CF4C=012C$01=.lC*.K.=.*C5.C-.##.CN#15.C.#C24C=012C
201"+4#.lCGC$+*#4-4$.*\C1,C)0*91K+4*.C5.C-0,2.,#.9.,#C2.*+C243,N(CC
qCF4C=012C^#.2C4,#N*.22N2C$+*C-.##.CN#15.\C9.*-4C5.C-0,#+-#.*CK.C`*0).22.1*CH*1,0CI*+-".#(C
F.2C-00*50,,N.2C20,#C)01*,4.2C-4/5.22012(CC
P0*2C5.CK+C$*.94M*.C=424#.\C24C=012C542$02.lC5O.6+9.,2C-099.C$+*C.6.9$K.C1,C
+15403*+99.\C+$$0*#.l/K.2(C].K+C$.*9.##*+C5.C=N*4)4.*C$K12C*+$45.9.,#C24C=012C$01=.lC
.,#*.*C5+,2CKQN#15.(CP.2C5N#+4K2C=012C2.*0,#C$*N2.,#N2\C.#CKON#15.C$01**+C5NZ1#.*(CC
C
En$conclusion$:$$
C
J,.C,01=.KK.C+$$*0-".C$01*CK.C#*+4#.9.,#C5.2C+-01$"M,.2C.2#C.,C5N=.K0$$.9.,#C$+*CK+C
20-4N#NCE.1*0FG2#.-(CC
C

!"##$%&&'''()*+,-./
+-01$".,.2(0*3&24#.&4,5.6($"$70$#40,8-09:-0,#.,#;#+2<8=4.';458>>?;@#.9458A?BC
Page 4 sur 4C
C
@KC2O+34#C5O4,2#4KK.*C21*CBCh01*2C1,C9N54-+9.,#C+,#4/+-01$"M,.\C54*.-#.9.,#C5+,2CKO0*.4KK.C
4,#.*,.\C+=.-C1,.C94-*0/$09$.(CC
C
J,C.22+4C-K4,4L1.C5.C$"+2.CAZ>C2.C5N*01K.C_CKQ"T$4#+KCU=4-.,,.\C5+,2CK.C].,#*.C
5O4,=.2#43+#40,C]K4,4L1.Cp]@]/[(CC
C
F4C=012C201"+4#.lC5.C$K12C+9$K.2C4,)0*9+#40,2\C24C=012C=01K.lC$+*#4-4$.*C_C-.##.CN#15.C
-K4,4L1.\C9.*-4C5.C-0,#+-#.*C%CC
C
K.C`*0).22.1*CH*1,0CI*+-".#C%CE.1*0FG2#.-C]0*$0*+#40,\Cg+,,CH409.54-+KC`+*<CC
P.2CN#15.2C5.CK+C$"+2.C@CHC20,#C.)).-#1N.2C21*C5.2C$.*20,,.2\C+)4,C5ON=+K1.*CK+C5.94/=4.\C
KO+Z20*$#40,\CK+C542#*4Z1#40,\CK+CZ40#*+,2)0*9+#40,C.#CKO.6-*N#40,C51C9N54-+9.,#C-".lC
KO"19+4,(CC
C
].2CN#15.2C50,,.,#CN3+K.9.,#C1,C+$.*d1C51C$*0)4KC5.C#0KN*+,-.C.#C5O4,,0-14#NC51C
9N54-+9.,#(Ci+,2CK.C-+2C$*N2.,#\C0,C#.2#.*+C+1224CK.2C.)).#2C21*CKO+-01$"M,.(CC
C
C
C>Ch14,C>YYWCC
C